January 2021 Report

New and First Time
Generic Drug Report

New Brand Drug Pipeline

Medication (Brand name) Drug Class Therapeutic Use Status Update
Celecoxib Oral Liquid (Elyxyb™) NSAID Migraine Headache Treatment Launch pending. Approved May 5, 2020.
Benzhydrocodone HCl/
Acetaminophen
(Apadaz™)
Opioid Analgesic –
Immediate Release
Pain Launch pending. Approved February 23, 2018.
Buprenorphine Depot
Injection
(Brixadi™)
Opioid Agonist Treatment of
Opioid Addiction
FDA declined to review December 2020.
Celecoxib/Tramadol NSAID/Opioid Agonist Pain FDA review pending.
Oxycodone Aximris XR™ Opioid Analgesic –
Extended Release
Pain FDA review pending.
Ansofaxine Antidepressant Major Depressive
Disorder
FDA review pending.
Naloxone Injection (Zimhi™) Opioid Antagonist Opioid Overdose FDA review pending.

Generic Pipeline

Medication (Brand name) Drug Class Therapeutic Use Status Update
Pregabalin Extended Release (Lyrica® CR) Anticonvulsant Neuropathic Pain Patent exclusivity expires April 2021.
Dabigatran (Pradaxa®) Anticoagulant Treatment/Prophylaxis of Deep Vein Thrombosis First patent set to expire December 2021.
Apixaban (Eliquis®) Anticoagulant Treatment/Prophylaxis of Deep Vein Thrombosis Generics approved December 23, 2019, but settlements expected to delay launch for at least a few years.
Naloxone HCl
(Narcan®) Nasal Spray
Opioid Antagonist Opioid Overdose Launch pending. Generic approved April 19, 2019.

Available in the Last 12 Months

Medication (Brand name) Drug Class Therapeutic Use Status Update
Oliceridine (Olinvyk™) Injection Opioid Agonist Pain November 2020
Tramadol Oral Solution (Qdolo™) Opioid Agonist Pain October 2020
Rimegepant (Nurtec™ ODT) CGRP Antagonist Migraine Headache Treatment March 2020
Ubrogepant (Ubrelvy™) CGRP Antagonist Migraine Headache Treatment March 2020

Newly Available Generics

Medication (Brand name) Drug Class Therapeutic Use Status Update
Meloxicam (Vivlodex®) NSAID Pain December 2020
Emtricitabine/Tenofovir
(Truvada®)
Antiretroviral HIV Post-Exposure
Prophylaxis
Generic anticipated late 2020.
Albuterol Sulfate (Proventil® HFA) Inhaled Bronchodilator Asthma April 2020
Naproxen/Esomeprazole (Vimovo®) NSAID/GI Protectant Pain/Stomach Ulcer Prophylaxis February 2020
Albuterol Sulfate (ProAir® HFA) Inhaled Bronchodilator Asthma February 2020

Discontinuations & Withdrawals

Medication (Brand name) Drug Class Therapeutic Use Status Update
Naloxone HCl (Evzio®) Opioid Antagonist Opioid Overdose The manufacturer made a business decision to discontinue in September 2020.
Albuterol Sulfate Inhaled Bronchodilator Asthma Perrigo Company recalled all lots of its generic inhaler in September 2020.
Ranitidine (Zantac®) H-2 Receptor Antagonist Heartburn/Stomach Ulcer Prophylaxis FDA asked all manufacturers to remove product from the market on April 1, 2020.
  • Stay Informed - Subscribe Today

  • This field is for validation purposes and should be left unchanged.